| Literature DB >> 26279685 |
Abstract
Major advances in pathology, molecular biology, patient diagnosis and care, as well as the advent of personalized therapy, have resulted in a greatly increased role for the pathologist, who has emerged as a key member of the lung cancer management team. A new multidisciplinary, clinically relevant classification of pulmonary adenocarcinoma has resulted in a paradigm shift in how we view and practice lung cancer pathology. In the future, the role of the pathologist will continue to grow and become fully integrated with clinical care.Entities:
Year: 2012 PMID: 26279685 PMCID: PMC4535720 DOI: 10.2217/lmt.12.43
Source DB: PubMed Journal: Lung Cancer Manag ISSN: 1758-1966